about
Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trialsSortases and the art of anchoring proteins to the envelopes of gram-positive bacteriaThe capsule of Porphyromonas gingivalis leads to a reduction in the host inflammatory response, evasion of phagocytosis, and increase in virulenceA search for small noncoding RNAs in Staphylococcus aureus reveals a conserved sequence motif for regulationReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsPathogenesis of methicillin-resistant Staphylococcus aureus infectionBacterial glycobiology: rhamnose-containing cell wall polysaccharides in Gram-positive bacteriaInvestigational drugs to treat methicillin-resistant Staphylococcus aureusStaphylococcal manipulation of host immune responsesWill there ever be a universal Staphylococcus aureus vaccine?Combating pathogenic microorganisms using plant-derived antimicrobials: a minireview of the mechanistic basisNeutrophils in innate host defense against Staphylococcus aureus infectionsNeutrophil-Mediated Phagocytosis of Staphylococcus aureusStructural Basis for the Regulation Mechanism of the Tyrosine Kinase CapB from Staphylococcus aureusA Structural Model of the Staphylococcus aureus ClfA–Fibrinogen Interaction Opens New Avenues for the Design of Anti-Staphylococcal TherapeuticsStructure Analysis of the Staphylococcus aureus UDP- N -acetyl-mannosamine Dehydrogenase Cap5O Involved in Capsular Polysaccharide BiosynthesisCrystal structure of the enzyme CapF of Staphylococcus aureus reveals a unique architecture composed of two functional domainsStructures of SdrD from Staphylococcus aureus reveal the molecular mechanism of how the cell surface receptors recognize their ligandsCrystal structure of the capsular polysaccharide synthesizing protein CapE of Staphylococcus aureusDynamic elements govern the catalytic activity of CapE, a capsular polysaccharide-synthesizing enzyme from Staphylococcus aureusDiscovery and characterization of natural tropolones as inhibitors of the antibacterial target CapF from Staphylococcus aureusStaphylococcal adaptation to diverse physiologic niches: an overview of transcriptomic and phenotypic changes in different biological environmentsIdentification and in vitro analysis of the GatD/MurT enzyme-complex catalyzing lipid II amidation in Staphylococcus aureusGlobal transcriptome analysis of Staphylococcus aureus response to hydrogen peroxideSynthetic teichoic acid conjugate vaccine against nosocomial Gram-positive bacteriaDetection of Alpha-Toxin and Other Virulence Factors in Biofilms of Staphylococcus aureus on Polystyrene and a Human Epidermal ModelPyruvate Oxidase as a Critical Link between Metabolism and Capsule Biosynthesis in Streptococcus pneumoniaeNatural mutations in a Staphylococcus aureus virulence regulator attenuate cytotoxicity but permit bacteremia and abscess formationTricarboxylic acid cycle-dependent synthesis of Staphylococcus aureus Type 5 and 8 capsular polysaccharides.Nucleotide biosynthesis is critical for growth of bacteria in human blood.Estimation of Staphylococcus aureus growth parameters from turbidity data: characterization of strain variation and comparison of methodsIdentification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection.Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia.Microarray analysis of toxicogenomic effects of ortho-phenylphenol in Staphylococcus aureus.The prevalence of antimicrobial resistance and carriage of virulence genes in Staphylococcus aureus isolated from food handlers in Kuwait City restaurants.Regulatory adaptation of Staphylococcus aureus during nasal colonization of humans.Influence of tigecycline on expression of virulence factors in biofilm-associated cells of methicillin-resistant Staphylococcus aureus.Looking toward basic science for potential drug discovery targets against community-associated MRSATwo novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection.Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis.
P2860
Q21131308-FAFD537F-8B15-48CA-94E8-9121990BEC39Q24544133-A079A350-F087-4921-A2F4-48A3ED28D6AAQ24609863-04598FE7-BF49-406A-9187-937B3985FB81Q24644403-FDD34B95-08CF-4EC7-9FB9-EA332EC32A96Q24646677-86F9F86B-F450-48B0-85BC-95E215433667Q24657579-715DE55C-96A0-4864-9AF1-D07C68D5563AQ26765815-C5E23B59-C67C-4044-B970-779D8E68161DQ26780246-8F094598-5BC7-44A8-8C33-F14ED37C9B4AQ26798461-10D0AAC7-036F-458A-8F37-499D72A3B576Q26824837-EC38F035-D258-41D2-91A6-53E80D3C5C67Q26851551-AA28EB7C-A94F-4143-B915-10D331BCD864Q27024628-520F864A-D527-4866-82E0-974CF8D1C349Q27025128-5BC82B55-A9BC-4705-8262-9E4D3F450A01Q27650793-54D6FEB3-461D-442A-9D44-22AB1B80CADBQ27653017-46E3ED4E-64F8-4FB3-96F9-4498B967A3FAQ27667366-9E2E1B25-6CA7-48A2-BFEA-B1D8C944B72BQ27677173-1E3CD500-20F3-49DD-B0CD-D3E850187260Q27677185-C1AD7ACE-7788-41CF-9EC5-D9F6069C1815Q27677521-F745E39F-309B-4083-A39A-EAE2D64CE0D0Q27687348-C124658D-D3FE-43A7-AD3F-DE0605611DC6Q27702303-D6CD968C-84B8-4A6D-ADDF-8B3BD249548AQ28087340-4AB47777-7CE4-4E38-B393-3D2F42473405Q28480400-0282A319-1BB4-4949-8543-A36181CC051CQ28485590-338114D3-3112-4C2B-BCCC-B2472595E673Q28543983-D80AC118-7689-4570-A043-880B809F4371Q28552176-8B6EB06F-C10D-4F6A-8E9B-0905AB1725B4Q28552778-4953FC77-B2D4-4831-955F-8F6252ACD587Q30017477-DB12C8B9-D16F-46ED-8989-B2FC32E32D35Q30434928-2457277B-3BC3-4141-9E85-C88C3BD8A1B8Q30841127-85AE135B-17DE-4053-B4E1-14DC686A5AB5Q31047917-CC8EA9A4-15A8-46ED-9B42-AA57A6DC0264Q33244198-CDF838EE-84E9-4E3E-A442-98CC4992FD03Q33321447-E5EDB0DA-D871-480C-A228-13E172734AD0Q33369551-0CD7E45F-B155-4576-A85E-6A605F8CE52CQ33468654-AE67132B-129A-4F68-9BE2-73A1D2253A4AQ33553375-0C44AA6F-1B20-4385-B7BD-5F30D838541DQ33559096-12E0587A-CF58-40E5-BDFC-B5935DAF54E5Q33560722-F6D1D4BD-FF8F-433A-9B15-2E6F12AC08EFQ33604815-5EC94D5B-A9A4-471D-80F6-4D97F0806654Q33622670-DADAC107-D62F-45EE-9F33-D76120184945
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Staphylococcus aureus capsular polysaccharides.
@ast
Staphylococcus aureus capsular polysaccharides.
@en
type
label
Staphylococcus aureus capsular polysaccharides.
@ast
Staphylococcus aureus capsular polysaccharides.
@en
prefLabel
Staphylococcus aureus capsular polysaccharides.
@ast
Staphylococcus aureus capsular polysaccharides.
@en
P2860
P1476
Staphylococcus aureus capsular polysaccharides.
@en
P2093
Jean C Lee
Katherine O'Riordan
P2860
P304
P356
10.1128/CMR.17.1.218-234.2004
P407
P577
2004-01-01T00:00:00Z